Mosquito salivary protein antibodies as efficient endpoints for vector control trials:A mechanistic comparison with clinical and entomological outcomesOA
Mosquito salivary protein antibodies as efficient endpoints for vector control trials:A mechanistic comparison with clinical and entomological outcomes
Peiyu Liu;Libin Rong;Derek Cummings;Matt Hitchings
Department of Biostatistics,University of Florida,Gainesville,FL,USA||Emerging Pathogens Institute,University of Florida,Gainesville,FL,USADepartment of Mathematics,University of Florida,Gainesville,32611,FL,USAJohns Hopkins Bloomberg School of Public Health,Baltimore,MD,USADepartment of Biostatistics,University of Florida,Gainesville,FL,USA||Emerging Pathogens Institute,University of Florida,Gainesville,FL,USA
Mosquito salivary proteinsMosquito bitesVector-borne diseasesClinical trials designMechanistic modelingStatistical analysis
Mosquito salivary proteinsMosquito bitesVector-borne diseasesClinical trials designMechanistic modelingStatistical analysis
《传染病建模(英文)》 2026 (4)
1368-1386,19
DC and MH were supported by the CDC-CFA award for the Atlantic Coast Center for Infectious Disease Dynamics and Analytics(ACCIDDA):NU38FT000012-01-00(UNC).LR was supported by the NSF grant DMS-2324692.
评论